The current price of SBRA is $20.90 — it has increased by 0.02% since the previous close. Data as of Nov 6, 2026.
SBRA is up 5.85% over the past week, up 9.40% over the past month and up 10.96% over the past year. The price is above its 200-day moving average of $20.00.
Analysts' average 12-month price target for SBRA is $21.86, which implies 4.62% upside from the current price. Individual estimates range from $20.00 to $23.00.
Sabra Health Care REIT, Inc. has a market capitalization of $5.47B. The company belongs to the Real Estate sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Sabra Health Care REIT, Inc. posted earnings of $0.11 per share against an estimate of $0.1637, missing expectations by 32.80%. Upcoming reports are listed in the earnings calendar.
Sabra Health Care REIT, Inc. reported revenue of $249.57M in its most recent quarter, which has increased by 31.32% compared with the same quarter a year earlier. Analysts had expected $236.64M.
Yes. Sabra Health Care REIT, Inc. pays dividends quarterly. The latest payment of $0.30 per share has a payment date of Nov 30, 2026, which corresponds to a dividend yield of 5.74%.
Companies most comparable to Sabra Health Care REIT, Inc. include Welltower Inc., Omega Healthcare Investors, Inc., Healthpeak Properties, Inc., American Healthcare REIT, Inc. and CareTrust REIT, Inc.
In the latest trading session SBRA moved between $20.65 and $21.05, a range of 1.91% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Sabra Health Care REIT, Inc. shows a buy rating today. Technical ratings are indicators, not investment advice.
Over the past 52 weeks SBRA has traded between $17.54 and $22.77. The current price is 8.23% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.